J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2005

Papers In Press, published online ahead of print April 1, 2005
J. Lipid Res., doi:10.1194/jlr.M500018-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500018-JLR200v1
46/6/1205    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, R. G.
Right arrow Articles by Rudel, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, R. G.
Right arrow Articles by Rudel, L. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on January 14, 2005
Revised on March 1, 2005
Accepted on March 16, 2005

ACAT2 contributes cholesteryl esters to newly secreted VLDL while LCAT adds CE to LDL in mice

Richard G. Lee, Ramesh Shah, Janet K. Sawyer, Robert L. Hamilton, John S. Parks, and Lawrence L. Rudel

Pathology, Wake Forest Univ. Health Sciences, Winston-Salem, NC 27157

Corresponding Author: lrudel{at}wfubmc.edu

The relative contributions of ACAT2 and LCAT to the CE content of VLDL and LDL were measured. ACAT2 deficiency led to a significant decrease in the percent CE (37.2±2.1% vs. 3.9±0.8%) in plasma VLDL, with a concomitant increase in the percent of TG (33.0±3.2% vs. 66.7±2.5%). Interestingly, the absence of ACAT2 had no apparent effect on the percentage CE in LDL, whereas LCAT deficiency significantly decreased the CE percentage (38.6±4.0% vs 54.6±1.9%) and significantly increased the percentage phospholipids (11.2±0.9% vs. 19.3±0.1%) of LDL. When both LCAT and ACAT2 were deficient, VLDL composition was similar to VLDL of the ACAT2 deficient mouse, while LDL were depleted in core lipids and enriched in surface lipids, appearing discoidal when observed by electron microscopy. We conclude that ACAT2 is important in synthesis of VLDL CE, while LCAT is important in remodeling of VLDL to LDL. Liver perfusions were performed and perfusate apoB accumulation rates in ACAT2 deficient mice were not significantly different from controls; perfusate VLDL CE decreased from 8.0 ± 0.8% in controls to 0 ± 0.7% in ACAT2 deficient mice. In conclusion, our data establish that ACAT2 provides core CE of newly secreted VLDL, while LCAT adds CE during LDL particle formation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
K. Minehira, S. G. Young, C. J. Villanueva, L. Yetukuri, M. Oresic, M. K. Hellerstein, R. V. Farese Jr., J. D. Horton, F. Preitner, B. Thorens, et al.
Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice
J. Lipid Res., September 1, 2008; 49(9): 2038 - 2044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Brown, T. A. Bell III, H. M. Alger, J. K. Sawyer, T. L. Smith, K. Kelley, R. Shah, M. D. Wilson, M. A. Davis, R. G. Lee, et al.
Targeted Depletion of Hepatic ACAT2-driven Cholesterol Esterification Reveals a Non-biliary Route for Fecal Neutral Sterol Loss
J. Biol. Chem., April 18, 2008; 283(16): 10522 - 10534.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. E. Temel, L. Hou, L. L. Rudel, and G. S. Shelness
ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins
J. Lipid Res., July 1, 2007; 48(7): 1618 - 1627.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. A. Spector and W. G. Haynes
LDL Cholesteryl Oleate: A Biomarker for Atherosclerosis?
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1228 - 1230.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. A. Bell III, K. Kelley, M. D. Wilson, J. K. Sawyer, and L. L. Rudel
Dietary Fat-Induced Alterations in Atherosclerosis Are Abolished by ACAT2-Deficiency in ApoB100 Only, LDLr-/- Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Joyce, E. M. Wagner, F. Basso, M. J. Amar, L. A. Freeman, R. D. Shamburek, C. L. Knapper, J. Syed, J. Wu, B. L. Vaisman, et al.
ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis
J. Biol. Chem., November 3, 2006; 281(44): 33053 - 33065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhou, Y. Zhai, Y. Mu, H. Gong, H. Uppal, D. Toma, S. Ren, R. M. Evans, and W. Xie
A Novel Pregnane X Receptor-mediated and Sterol Regulatory Element-binding Protein-independent Lipogenic Pathway
J. Biol. Chem., May 26, 2006; 281(21): 15013 - 15020.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
B. Zhao, R. Natarajan, and S. Ghosh
Human liver cholesteryl ester hydrolase: cloning, molecular characterization, and role in cellular cholesterol homeostasis
Physiol Genomics, November 17, 2005; 23(3): 304 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. E. Temel, R. G. Lee, K. L. Kelley, M. A. Davis, R. Shah, J. K. Sawyer, M. D. Wilson, and L. L. Rudel
Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2
J. Lipid Res., November 1, 2005; 46(11): 2423 - 2431.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.